Jundishapur Journal of Chronic Disease Care

Published by: Kowsar

Prevalence of Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Sleeve Bariatric Surgery in Iran and Association With Other Comorbid Conditions

Hamidreza Karimi-Sari 1 , Seyed Morteza Mousavi-Naeini 2 , * , Mahdi Ramezani-Binabaj 1 , Shahriar Najafizadeh-Sari 1 , Mohammad Hosein Mir-Jalili 1 and Fardin Dolatimehr 1
Authors Information
1 Students’ Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Department of Surgery, Trauma Research Center, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Jundishapur Journal of Chronic Disease Care: April 01, 2015, 4 (2); e25128
  • Published Online: April 20, 2015
  • Article Type: Research Article
  • Received: November 4, 2014
  • Revised: January 12, 2015
  • Accepted: January 21, 2015
  • DOI: 10.5812/jjcdc.25128

To Cite: Karimi-Sari H, Mousavi-Naeini S M, Ramezani-Binabaj M, Najafizadeh-Sari S, Mir-Jalili M H, et al. Prevalence of Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Sleeve Bariatric Surgery in Iran and Association With Other Comorbid Conditions, Jundishapur J Chronic Dis Care. 2015 ; 4(2):e25128. doi: 10.5812/jjcdc.25128.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Cerda C, Perez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol. 2007; 47(3): 412-7[DOI][PubMed]
  • 2. Vassilatou E, Lafoyianni S, Vryonidou A, Ioannidis D, Kosma L, Katsoulis K, et al. Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. Hum Reprod. 2010; 25(1): 212-20[DOI][PubMed]
  • 3. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011; 34(3): 274-85[DOI][PubMed]
  • 4. Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut. 2010; 59(10): 1410-5[DOI][PubMed]
  • 5. Angulo P. Obesity and nonalcoholic fatty liver disease. Nutr Rev. 2007; 65(6 Pt 2)-63[PubMed]
  • 6. Hurt RT, Frazier TH, McClave SA, Kaplan LM. Obesity epidemic: overview, pathophysiology, and the intensive care unit conundrum. JPEN J Parenter Enteral Nutr. 2011; 35(5 Suppl): 4S-13S[DOI][PubMed]
  • 7. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010; 51(2): 679-89[DOI][PubMed]
  • 8. Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006; 45(4): 600-6[DOI][PubMed]
  • 9. Dolce CJ, Russo M, Keller JE, Buckingham J, Norton HJ, Heniford BT, et al. Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery. Surg Obes Relat Dis. 2009; 5(3): 323-8[DOI][PubMed]
  • 10. Weiner RA. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Dig Dis. 2010; 28(1): 274-9[DOI][PubMed]
  • 11. Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 2010; 51(1): 121-9[DOI][PubMed]
  • 12. Cottam D, Qureshi FG, Mattar SG, Sharma S, Holover S, Bonanomi G, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006; 20(6): 859-63[DOI][PubMed]
  • 13. Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg. 2004; 14(4): 492-7[DOI][PubMed]
  • 14. Lee CM, Cirangle PT, Jossart GH. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc. 2007; 21(10): 1810-6[DOI][PubMed]
  • 15. Schirmer B, Jones DB. The American College of Surgeons Bariatric Surgery Center Network: establishing standards. Bull Am Coll Surg. 2007; 92(8): 21-7[PubMed]
  • 16. Clinical Issues Committee of the American Society for M, Bariatric S. Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis. 2010; 6(1): 1-5[DOI][PubMed]
  • 17. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012; 55(6): 2005-23[DOI][PubMed]
  • 18. Jamali R. Non-Alcoholic Fatty Liver Disease: Diagnosis and Evaluation of Disease Severity. Thrita J Med Sci. 2013; 2(2): 43-51[DOI]
  • 19. Harnois F, Msika S, Sabate JM, Mechler C, Jouet P, Barge J, et al. Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery. Obes Surg. 2006; 16(2): 183-8[DOI][PubMed]
  • 20. Gholam PM, Kotler DP, Flancbaum LJ. Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. Obes Surg. 2002; 12(1): 49-51[DOI][PubMed]
  • 21. Beymer C, Kowdley KV, Larson A, Edmonson P, Dellinger EP, Flum DR. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg. 2003; 138(11): 1240-4[DOI][PubMed]
  • 22. Moretto M, Kupski C, Mottin CC, Repetto G, Garcia Toneto M, Rizzolli J, et al. Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities. Obes Surg. 2003; 13(4): 622-4[PubMed]
  • 23. Spaulding L, Trainer T, Janiec D. Prevalence of non-alcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass. Obes Surg. 2003; 13(3): 347-9[DOI][PubMed]
  • 24. Abrams GA, Kunde SS, Lazenby AJ, Clements RH. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. Hepatology. 2004; 40(2): 475-83[DOI][PubMed]
  • 25. Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg. 2005; 15(3): 310-5[DOI][PubMed]
  • 26. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002; 123(3): 745-50[PubMed]
  • 27. Boza C, Riquelme A, Ibanez L, Duarte I, Norero E, Viviani P, et al. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. Obes Surg. 2005; 15(8): 1148-53[DOI][PubMed]
  • 28. Feijo SG, Lima JM, Oliveira MA, Patrocinio RM, Moura-Junior LG, Campos AB, et al. The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors. Acta Cir Bras. 2013; 28(11): 788-93[PubMed]
  • 29. Holterman AX, Guzman G, Fantuzzi G, Wang H, Aigner K, Browne A, et al. Nonalcoholic fatty liver disease in severely obese adolescent and adult patients. Obesity (Silver Spring). 2013; 21(3): 591-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments